Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|December 11, 2023
Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoiresMichael Volkmar, Elham Fakhr, Stefan Zens, et al.
Blood|October 24, 2002
Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expressionAndrea M Woltman, Sandra W van der Kooij, Paul J Coffer, et al.
Scientific Reports|January 22, 2020
Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell linePhilipp Schröter, Laura Hartmann, Wolfram Osen, et al.
Oncogene|August 11, 2005
Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancyNiels Smakman, Liesbeth M Veenendaal, Paul van Diest, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 3, 2002
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitopeLukas C Heukamp, Thorbald van Hall, Ferry Ossendorp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1Thorbald van Hall, Sandra Laban, Danijela Koppers-Lalic, et al.
Cancer Research|August 3, 2005
CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hostsAnnemieke Th den Boer, Geertje J D van Mierlo, Marieke F Fransen, et al.
Bio-Protocol|April 30, 2024
T-Cell-Based Platform for Functional Screening of T-Cell Receptors Identified in Single-Cell RNA Sequencing Data Sets of Tumor-Infiltrating T-CellsAaron Rodriguez Ehrenfried, Stefan Zens, Laura K Steffens, et al.
Cancer Research|July 19, 2005
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoireRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
The tumoricidal activity of memory CD8+ T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environmentAnnemieke Th den Boer, Geertje J D van Mierlo, Marieke F Fransen, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|December 11, 2023
Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoiresMichael Volkmar, Elham Fakhr, Stefan Zens, et al.
Blood|October 24, 2002
Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expressionAndrea M Woltman, Sandra W van der Kooij, Paul J Coffer, et al.
Scientific Reports|January 22, 2020
Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell linePhilipp Schröter, Laura Hartmann, Wolfram Osen, et al.
Oncogene|August 11, 2005
Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancyNiels Smakman, Liesbeth M Veenendaal, Paul van Diest, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 3, 2002
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitopeLukas C Heukamp, Thorbald van Hall, Ferry Ossendorp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1Thorbald van Hall, Sandra Laban, Danijela Koppers-Lalic, et al.
Cancer Research|August 3, 2005
CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hostsAnnemieke Th den Boer, Geertje J D van Mierlo, Marieke F Fransen, et al.
Bio-Protocol|April 30, 2024
T-Cell-Based Platform for Functional Screening of T-Cell Receptors Identified in Single-Cell RNA Sequencing Data Sets of Tumor-Infiltrating T-CellsAaron Rodriguez Ehrenfried, Stefan Zens, Laura K Steffens, et al.
Cancer Research|July 19, 2005
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoireRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
The tumoricidal activity of memory CD8+ T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environmentAnnemieke Th den Boer, Geertje J D van Mierlo, Marieke F Fransen, et al.
Pageof 12